IASLC 18th World Conference on Lung Cancer, Yokohama, Japan

Xcovery is presenting a mini-oral presentation entitled: Response to Ensartinib in TKI naïve ALK+ NSCLC patients Heather A. Wakelee, Rachel E. Sanborn, Jorge Nieva,  Saiama Naheed Waqar, Christina E. Brzezniak, Jessica Bauman, Joel W. Neal,  Gary Dukart,  Fenlai Tan, Kimberly Harrow, Chris Liang, Leora Horn Ensartinib has shown clinical activity in patients harboring an ALK […]